Magnetic Resonance Imaging with Superparamagnetic Iron Oxide Fails to Track the Long-term Fate of Mesenchymal Stem Cells Transplanted into Heart

Scientific Reports

Volumn 5, Issue , 2015, Pages

  Ma, Ning ^a,c   Cheng, Huaibing ^a,d   Lu, Minjie ^a   Liu, Qiong ^a   Chen, Xiuyu ^a   Yin, Gang ^a   Zhu, Hao ^b   Zhang, Lianfeng ^b   Meng, Xianmin ^a   Tang, Yue ^a   Zhao, Shihua ^a  

^a FUWAI HOSPITAL   (China)

^b INSTITUTE OF LABORATORY ANIMAL SCIENCE   (China)

^c CAPITAL MEDICAL UNIVERSITY   (China)

^d PEKING UNION MEDICAL COLLEGE   (China)

Author keywords

[No Author keywords available]

Indexed keywords

MAGNETITE NANOPARTICLE;

ANIMAL; APOPTOSIS; CELL TRACKING; CYTOLOGY; DISEASE MODEL; FLUORESCENCE MICROSCOPY; HEART LEFT VENTRICLE FUNCTION; MACROPHAGE; MALE; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYMAL STROMA CELL; METABOLISM; MORTALITY; MYOCARDIAL INFARCTION; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOLOGY; RAT;

ANIMALS; APOPTOSIS; CELL TRACKING; DISEASE MODELS, ANIMAL; MACROPHAGES; MAGNETIC RESONANCE IMAGING; MAGNETITE NANOPARTICLES; MALE; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYMAL STROMAL CELLS; MICROSCOPY, FLUORESCENCE; MYOCARDIAL INFARCTION; RATS; VENTRICULAR FUNCTION, LEFT;

EID: 84924857127     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep09058     Document Type: Article

References (29)

1. Segers, V. F. & Lee, R. T. Stem-cell therapy for cardiac disease. Nature 451, 937-942 (2008).
2. Nesselmann, C. et al.Mesenchymal stem cells and cardiac repair. J Cell Mol Med. 12, 1795-1810 (2008).
3. Dai, W. et al. Allogeneic mesenchymal stem cell transplantation in postinfarcted rat myocardium: short- and long-term effects. Circulation 112, 214-223 (2005).
4. Miyahara, Y. et al. Monolayered mesenchymal stem cells repair scarred myocardium after myocardial infarction. Nat Med. 12, 459-465 (2006).
5. Karpov, A. A. et al. The effect of bone marrow- and med adipose tissue-derivesenchymal stem cell transplantation on myocardial remodelling in the rat model of ischaemic heart failure. Int J Exp Pathol. 94, 169-177 (2013).
6. Muscari, C. et al . Restored perfusion and reduced inflammation in the infarcted heart after grafting stem cells with a hyaluronan-based scaffold. J Cell Mol Med. 17, 518-530 (2013).
7. Strauer, B. E., Yousef, M. & Schannwell, C. M. The acute and long-term effects of intracoronary Stem cell Transplantation in 191 patients with chronic heARt failure: the STAR-heart study. Eur J Heart Fail 12, 721-729 (2010).
8. raverse, J. H. et al. Effect of intracoronary delivery of autologous bone marrow mononuclear cells 2 to 3 weeks following acute myocardial infarction on left ventricular function: the LateTIME randomized trial. JAMA 306, 2110-2119 (2011).
9. Jeevanantham, V. et al. Adult bone marrow cell therapy improves survival and induces long-term improvement in cardiac parameters: a systematic review and meta-analysis. Circulation 126, 551-568 (2012).
10. Frank, J. A. et al.Magnetic intracellular labeling of mammalian cells by combining (FDA-approved) superparamagnetic iron oxide MR contrast agents and commonly used transfection agents. Acad Radiol. 9, S484-487 (2002).
11. Arbab, A. S. et al. Characterization of biophysical andmetabolic properties of cells labeled with superparamagnetic iron oxide nanoparticles and transfection agent for cellular MR imaging. Radiology 229, 838-846 (2003).
12. Chen, I. Y. et al. Comparison of optical bioluminescence reporter gene and superparamagnetic iron oxide MR contrast agent as cell markers for noninvasive imaging of cardiac cell transplantation. Mol Imaging Biol. 11, 178-187 (2008).
13. Amsalem, Y. et al. Iron-oxide labeling and outcome of transplanted mesenchymal stem cells in the infarcted myocardium. Circulation 116, I38-45 (2007).
14. Winter, E. M. et al. Cell tracking using iron oxide fails to distinguish dead from living transplanted cells in the infarcted heart. Magn Reson Med. 63, 817-821 (2010).
15. Terrovitis, J. et al.Magnetic resonance imaging overestimates ferumoxide-labeled stem cell survival after transplantation in the heart. Circulation 117, 1555-1562 (2008).
16. Wang, W. et al. Intravenous administration of bone marrow mesenchymal stromal cells is safe for the lung in a chronic myocardial infarction model. Regen Med. 6, 179-190 (2011).
17. Zhang, Q. et al . Autophagy activation: a novel mechanism of atorvastatin to protect mesenchymal stem cells from hypoxia and serum deprivation via AMPactivated protein kinase/mammalian target of rapamycin pathway. Stem Cells Dev. 21, 1321-32 (2012).
18. Wang, J. et al. MicroRNA-193 pro-proliferation effects for bone mesenchymal stem cells after low-level laser irradiation treatment through inhibitor of growth family, member 5. Stem Cells 13, 2508-19 (2012).
19. Jiang, Q. et al. Remote ischemic postconditioning enhances cell retention in the myocardium after intravenous administration of bone marrow mesenchymal stromal cells. J Mol Cell Cardiol. 56, 1-7 (2013).
20. Min, J. Y. et al.Homing of intravenously infused embryonic stem cell-derived cells to injured hearts after myocardial infarction. J Thorac Cardiovasc Surg. 131, 889-897 (2006).
21. Smits, A. M. et al. Human cardiomyocyte progenitor cell transplantation preserves long-term function of the infarcted mouse myocardium. Cardiovasc Res. 83, 527-535 (2009).
22. Ziebart, T. et al. Sustained persistence of transplanted proangiogenic cells contributes to neovascularization and cardiac function after ischemia. Circ Res. 103, 1327-1334 (2008)
23. Carr, C. A. et al. Bone marrow-derived stromal cells home to and remain in the infarcted rat heart but fail to improve function: an in vivo cine-MRI study. Am J Physiol Heart Circ Physiol. 295, H533-542 (2008).
24. Wöhrle, J. et al. Results of intracoronary stem cell therapy after acute myocardial infarction. Am J Cardiol. 105, 804-812 (2010).
25. Qiao, H. et al. Long-term improvement in postinfarct left ventricular global and regional contractile function is mediated by embryonic stem cell-derived cardiomyocytes. Circ Cardiovasc Imaging 4, 33-41 (2011).
26. López, Y. et al. Wharton's jelly or bone marrow mesenchymal stromal cells improve cardiac function followingmyocardial infarction for more than 32 weeks in a rat model: a preliminary report. Curr Stem Cell Res. Ther. 8, 46-59 (2013).
27. Küstermann, E. et al. Stem cell implantation in ischemic mouse heart: a high-resolution magnetic resonance imaging investigation. NMR Biomed 18, 362-370 (2005).
28. Hinds, K. A. et al.Highly efficient endosomal labeling of progenitor and stem cells with large magnetic particles allows magnetic resonance imaging of single cells. Blood 102, 867-872 (2003).
29. Kraitchman,D. L. et al. In vivo magnetic resonance imaging ofmesenchymal stem cells in myocardial infarction. Circulation 107, 2290-2293 (2003).